

2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Catalio Access Fund XII | August 2026 | $20M | $20M | 54 |
| Catalio Access Fund XI | April 2026 | $16M | $16M | 14 |
| Catalio Inflection Fund III | April 2026 | $8M | $8M | 12 |
| Catalio Inflection Fund II | April 2026 | $10M | $10M | 14 |
| Catalio Access Fund IX | March 2026 | $17M | $17M | 41 |
| Catalio Access Fund X | March 2026 | $20M | $20M | 19 |
| Catalio Access Fund VIII | March 2026 | $25M | $25M | 68 |
| Catalio Genesis Fund X | February 2026 | $19M | $19M | 57 |
| Catalio Genesis Fund IX | June 2025 | $8.6M | $8.6M | 24 |
| Catalio Genesis Fund VIII | April 2025 | $15M | $15M | 32 |
| Catalio Genesis Fund VI | April 2025 | $15M | $15M | 30 |
| Catalio Inflection Fund I | March 2025 | $13M | $13M | 36 |
| Catalio Access Fund VII | June 2024 | $5M | $5M | 29 |
| Catalio Nexus Offshore Fund IV | March 2024 | Indefinite | $43M | 29 |
| Catalio Structured Opportunities Offshore Fund II | 2024 | Indefinite | $123M | 41 |
| Catalio Structured Opportunities Fund II | 2024 | Indefinite | $179M | 93 |
| Catalio Nexus Fund IV | August 2023 | Indefinite | $358M | 270 |
| Catalio Special Opportunities Fund III | December 2021 | $4M | $4M | 23 |
| Catalio Access Fund V | September 2021 | $16M | $16M | 60 |
| Catalio Structured Opportunities Fund I | August 2021 | $200M | $86M | 83 |
| Catalio Genesis Fund II | June 2021 | $46M | $46M | 96 |
| Catalio Nexus Fund III | April 2021 | $384M | $384M | 324 |
| Catalio Public Equities Offshore Fund | December 2020 | Indefinite | $142M | 32 |
| Catalio Public Equities Fund | August 2020 | Indefinite | $84M | 51 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
4 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| George Petrocheilos | Slowing | None listed | 4 | 1 |
| Georgios PetrocheilosNot on the current fund | Quiet | None listed | 0 | 0 |
| Olga MaltsevaNot on the current fund | Quiet | None listed | 1 | 0 |
| R. Vogelstein | Quiet | Biotech & pharma | 1 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Too few companies classified yet to infer a focus. 1 of 5 portfolio companies are classified.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Catalio Capital Management’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Third Rock Ventures | 1 | ManaT Bio |
| Vivo Capital | 1 | ManaT Bio |
A shared board seat: a company where filings name a Catalio Capital Management partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.